,0
0,New Data Presented at EACS 2023 Further Demonstrate Strong Clinical Profile of Twice-Yearly Sunlenca® for Adults With Multi-Drug Resistant HIV
1,GILD or VRTX: Which Is the Better Value Stock Right Now?
2,OPCH or CHE: Which Is the Better Value Stock Right Now?Zacks
3,HTHIY vs. HON: Which Stock Is the Better Value Option?Zacks
4,"Insider Sell: CFO Andrew Dickinson Sells 5,000 Shares of Gilead Sciences Inc"
5,Real-World Evidence Reinforces Biktarvy® as a Long-Term Treatment Option With a High Barrier to Resistance for People With HIV and a Range of Comorbidities
6,Why AstraZeneca's Disappointing Lung Cancer Update Also Tripped Gilead Stock
7,Gilead Sciences Announces New Clinical Trial in Europe to Assess Lenacapavir for HIV Prevention as Part of Landmark Purpose Program
8,Gilead Sciences: Leading With Passion and Purpose: Sandra’s Story
9,Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases
10,Gilead Sciences (GILD) Beats Stock Market Upswing: What Investors Need to Know
11,Jim Simons Stock Portfolio: Top 10 Stock Picks
